Methylphenidate Discontinuation and Reinitiation during Long-Term Treatment of Children with Tourette's Disorder and Attention-Deficit Hyperactivity Disorder: A Pilot Study

Journal of Child and Adolescent Psychopharmacology

Volumn 5, Issue 3, 1995, Pages 205-214

  Riddle, Mark A ^a   Lynch, Kimberly A ^a,b   Scahill, Lawrence ^a,b   Devries, Annelou ^a,b   Cohen, Donald J ^a,b   Leckman, James F ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; MALE; SCHOOL CHILD;

EID: 0028863189     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.1995.5.205     Document Type: Article

References (28)

1. Barkley RA, McMurray MB, Edelbrock CS, Robins K: Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic, placebo-controlled evaluation. Pediatrics 86:198-202, 1990.
2. Bremness AB, Sverd J: Methylphenidate-induced Tourette syndrome: Case report. Am J Psychiat 136:1334-1335, 1979.
3. Caine ED, Ludlow CL, Polinsky RJ, Ebert MH: Provocative drug testing in Tourette's syndrome: d- and 1-amphetamine and haloperidol. J Am Acad Child Psychiat 23:147-152, 1984.
4. Castellanos FX, Rapoport JL: Stimulant treatment of pediatric Tourette disorder and ADHD [abstract]. Annual Meeting of the American College of Neuropsychopharmacology, 1992, p 154.
5. Chappell PB, Leckman JF, Scahill LD, Hardin MT, Anderson G. Cohen DJ: Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: A pilot study. Psychiat Res 47:267-280, 1993.
6. Chappell PB, McSwiggan-Hardin MT, Scahill L. Rubenstein M. Walker DE, Cohen DJ, Leckman DJ: Videotape tic counts in the assessment of Tourette's syndrome: Stability, reliability, and validity. J Am Acad Child Adolesc Psychiat 33:386-393, 1994.
7. Cohen DJ, Leckman JF: Commentary. J Am Acad Child Adolesc Psychiat 28:580-582, 1989.
8. Denckla MB, Bemporad JR, MacKay MC: Tics following methylphenidate administration. JAMA 235:1349-1351, 1976.
9. Erenberg G. Cruse RP, Rothner AD: Gilles de la Tourette's syndrome: Effects of stimulant drugs. Cleve Clin Q 53:127-131, 1985.
10. Feinberg M. Carroll BJ: Effects of dopamine agonists in Tourette's disease. Arch Gen Psychiat 44:1025-1026, 1979.
11. Gadow KD, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiat 31:462-471, 1992.
12. Golden GS: Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 16:76-78, 1974.
13. Golden GS: The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol 2:69-70, 1977.
14. Golden GS: Letter to the editor, JAMA 248:1063, 1982.
15. Ickowicz A. Tannock R. Fulford P. Purvis K. Schachar R: Transient tics and compulsive behavior following methylphenidate: Evidence from a placebo controlled double blind clinical trial [abstract]. Scientific Proceedings of the 39th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 1992, p 70.
16. Kazdin AE: Single-Case Research Designs: Methods for Clinical and Applied Settings. New York, Oxford University Press, 1982.
17. Leckman JF, Towbin KE, Ort SI, Cohen DJ: Clinical assessment of tic disorder severity. In: Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. Edited by Cohen DJ, Bruun RD, Leckman JF. New York, John Wiley, 1988, pp 56-78.
18. Leckman JF, Riddle MA, Hardin MT, Ort SI, Scartz KL, Stevenson J. Cohen DJ: The Yale Global Tic Severity Scale: Initial testing of a clinic-rated scale of tic severity. J Am Acad Child Adolesc Psychiat 28:566-573, 1989.
19. Lowe TL, Cohen DJ, Detlor J. Kremenitzer MW, Shaywitz BA: Stimulant medications precipitate Tourette's syndrome. JAMA 247:1729-1731, 1982.
20. Meyerhoff JL, Snyder SH: Gilles de la Tourette's disease and minimal brain dysfunction: Amphetamine isomers reveal catecholamine correlates in an affected patient. Psychopharmacologia 29:211-220, 1973.
21. Mitchell E. Matthews KL: Gilles de la Tourette's disorder associated with pemoline. Am J Psychiat 137:1618-1619, 1980.
22. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF: A twin study of Tourette syndrome. Arch Gen Psychiat 42:815-820, 1985.
23. Price AR, Leckman JF, Pauls DL, Cohen DJ, Kidd KK: Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and nontwins. Neurology 36:232-237, 1986.
24. Singer K: Gilles de la Tourette's disease. Am J Psychiat 120:80-81, 1963.
25. Sprafkin J. Gadow KD: Four purported cases of methylphenidate-induced tic exacerbation: Methodological and clinical doubts. J Child Adolesc Psychopharmacol 3:231-244, 1993.
26. Sverd J. Gadow KD, Paolicelli LM: Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette syndrome. J Am Acad Child Adolesc Psychiat 28:574-579, 1989
27. Sverd J. Gadow KD, Nolan EE, Sprafkin J. Ezor SN: Methylphenidate in hyperactive boys with comorbid tic disorder: I. Clinic evaluations. In: Advances in Neurology, vol 58: Tourette Syndrome 2: A Decade of Progress. Edited by Chase TN, Friedhoff AJ, Cohen DJ. New York, Raven Press, 1992.
28. Voeller KS, Marcus BA, Lewis MH: Multiple estimates of dopaminergic function in ADHD children [abstract]. Biol Psychiat 33: 110A, 1993.